BRS-X-ECS-1-3 - FAAH-Mediated Endocannabinoid Preservation

1. Mission & Overview

Mission

Preserve endocannabinoid signalling duration by limiting FAAH-mediated degradation of anandamide and related NAEs.

Intervention Dominance: Diet-Supported — No principal intervention route established

The inherited intervention qualification is not confirmed by a mission-specific dietary/practice effect in this assessment.

Overview

FAAH is an enzyme that breaks down anandamide and related signalling lipids. Its activity helps determine how long a locally produced signal remains available. Rat pharmacology and laboratory assays establish that changing this clearance step can alter anandamide effects. They do not establish that eating soy, polyphenol-rich foods or a general phospholipid diet inhibits brain FAAH. The useful distinction is between a verified clearance mechanism and a dietary intervention that still needs exposure-specific evidence. Thors et al. (2007) [1]; Solinas et al. (2006) [2]

• Biological Relevance: FAAH inhibition prolonged the rapid CB1-sensitive dopamine response; a later component differed pharmacologically. Solinas et al. (2006) [2]

2. Primary Biological Effects

• FAAH inhibition prolonged the rapid CB1-sensitive dopamine response; a later component differed pharmacologically. Solinas et al. (2006) [2]
• Genistein and daidzein altered anandamide uptake under the tested laboratory conditions. Thors et al. (2007) [1]

3. Levers

4. Mechanistic Basis

Summary

FAAH inhibition prolonged the rapid CB1-sensitive dopamine response; a later component differed pharmacologically. Solinas et al. (2006) [2]

Mechanism boundary: Food-level genistein exposure to relevant neural FAAH inhibition and signal duration is unestablished. Probiotic serum FAAH concentration is not a brain enzyme-activity assay.

4.1 Scientific Findings (2)

Scientific Findings and their source assessments are available in Evidence & Audit.

5. BRS Pathways and Connections

5.1 BRS Pathways

• None listed

5.2 Cross-BRS Mechanism Relationships

Primary Mechanisms in other Biological Regulatory Systems that directly interact with, constrain or support this mechanism.

• BRS-X(ECS-FM1) — Endocannabinoidome Signalling Capacity & Neuromodulatory Regulation — Parent integration combines these child processes without establishing a new nutrient or outcome claim.
• BRS-X(ECS-PM1) — NAPE → NAE Biosynthesis Capacity — Supplies NAE formation; downstream signal clearance and receptor responses remain separate jobs.
• BRS1-FM3-PM7 — Neuronal Membrane DHA Incorporation — DHA is shared lipid context, but membrane incorporation and ethanolamide formation are separately measured processes.
• BRS1(FM1) — Monoaminergic Function — Candidate contextual connection retained for review; an exposure-specific resource or signalling relationship is not yet characterised.
• BRS6(FM2) — HPA Axis Rhythm & Cortisol Regulation — Stress-axis output is an interfacing endpoint; the regional endocannabinoid route is qualified separately from general cortisol regulation.

5.3 Local BRS Mechanism Relationships

Related Primary Mechanisms within the same Biological Regulatory System that collectively support the integrated biological function.

• BRS-X(ECS-PM1) — NAPE → NAE Biosynthesis Capacity — Supplies NAE formation; downstream signal clearance and receptor responses remain separate jobs.
• BRS-X(ECS-PM4) — Endocannabinoid–Dopamine Neuromodulation — Tests local dopamine-circuit responses to endocannabinoids; precursor availability does not establish the circuit response.

Phenome assessment boundary: Existing ratings and their original source records are retained pending outcome reassessment. The new mechanism and lever Findings do not validate or raise those ratings.

7. Phenome Connections

These mappings are translational relationships, not single-mechanism outcome claims. Phenomes are emergent functional patterns supported by multiple interacting PMs across the BRAIN Framework.

Stress Resilience — modulatesOpen Page →→

Emotional Regulation — modulatesOpen Page →→

8. References

• [1] Thors et al. (2007) — Inhibition of the Cellular Uptake of Anandamide by Genistein and Its Analogue
• [2] Solinas et al. (2006) — Anandamide Administration Alone and After Inhibition of Fatty Acid Amide Hydrolase (FAAH)